Skip to main content
OpenTrials

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

397 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Histiocytosis trial results

Completed

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

NCT01998633

Conditions
Blood Protein Disorders, Chronic Active Epstein-Barr Virus Infection, Chronic Disease, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

Human Placental-Derived Stem Cell Transplantation

NCT01586455

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
Locations
  • Children's Hospital Colorado Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
  • University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

NCT02069899

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, Histiocytosis, +3 more
Locations
  • Spectrum Health Helen Devos Children's Hospital Grand Rapids, Michigan, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital - Division of Immunobiology Cincinnati, Ohio, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View all 16 locations
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

NCT03311854

Conditions
Adult Onset Still Disease, Arthritis, Arthritis, Juvenile, +17 more
Locations
  • Cincinnati Children'S Hospital Cincinnati, Ohio, United States
  • Hôpital Necker-Enfants Malades, Unité d'Immunologie-hématologie et Rhumatologie pédiatriques Paris, France
  • IRCCS Ospedale Pediatrico, Bambino Gesù Rome, Italy
  • Hospital Sant Joan de Deu Barcelona, Spain
View Trial Details
Completed

Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency

NCT02292654

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • Investigational Site Number 840001 New York, United States
  • Investigational Site Number 076001 Porto Alegre, Brazil
  • Investigational Site Number 250002 Bron, France
  • Investigational Site Number 276001 Mainz, Germany
View Trial Details

Related conditions